Abstract
The scientific article is devoted to evaluation of the original author's composition effectiveness for prevention and treatment of dyspepsia in newborn calves from BLV-infected cows. It is shown that use of the composition for prophylactic purposes reduces possibility of dyspepsia development in 20.82 % calves, and for therapeutic purposes reduces the treatment duration of dyspeptic manifestations in 28.35 % of newborn calves up to 3 days and increases the safety of livestock up to 100%. The obtained data are supported by the results of morphological and biochemical analyses of calves' blood, microbiological studies of the intestinal contents, indicating a rapid recovery of the animal homeostasis with opportune use of the composition for preventive or therapeutic purposes. It was found that use of the author's development allows us to keep the weight gain in calves from immunocompromised mothers at the level of intact animals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Scientific Notes Kazan Bauman State Academy of Veterinary Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
